Technology | March 22, 2007

ACC: GE's New Electrocardiograph Unit Improves Reliability, Accuracy


Ideal for basic 12-lead resting ECG analysis, the MAC 3500 electrocardiograph unit delivers technology to help clinicians improve reliability and accuracy in cardiac assessments, while also helping to increase productivity and efficiency.

The MAC 3500 includes GE’s clinically proven Marquette ECG analysis programs: Marquette 12SL ECG simultaneous 12-lead ECG analysis program for adults and pediatrics – the industry’s most clinically validated program; Marquette Hookup Advisor signal quality analysis program, which reviews and measures ECG waveforms for signs of artifact and interference, helping to eliminate poor waveform quality during the recording of ECGs; and Marquette 12SL with Gender-Specific Interpretation that improves a clinician’s ability to detecting acute myocardial infarction (MI) in women.

An optional communications package with GE’s MUSE cardiology information system helps streamline workflow and helps increase functionality. Bar code and magnetic card reader options help reduce errors and help improve workflow by automating data input and patient identification.


Related Content

Feature | ECG | Samir Awasthi, MD, PhD

For decades, medicine has treated the electrocardiogram as a familiar, inexpensive and indispensable test, but also as ...

Home June 16, 2026
Home
News | ECG

June 2, 2026 —HeartSciences Inc. has announced the commercial release of MyoVista Insights version 1.3, a major platform ...

Home June 05, 2026
Home
News | ECG

June 2, 2026 — AccurKardia, Inc. has been granted US Patent No. 12,620,488 for the company's proprietary machine ...

Home June 02, 2026
Home
News | ECG

May 7, 2026 — AccurKardia, a provider of ECG-based diagnostics technology, recently announced that AK+ Guard has been ...

Home May 08, 2026
Home
News | ECG

April 15, 2026 – AliveCor has received CE Mark (Conformité Européenne) for the Kardia 12L electrocardiogram (ECG) System ...

Home April 15, 2026
Home
News | ECG

March 4, 2026 — HeartBeam, Inc. has announced a commercial partnership with ClearCardio. In addition to serving as ...

Home March 06, 2026
Home
News | ECG

March 3, 2026 — BioCardia, Inc., a developer of cellular and cell-derived therapeutics for treating cardiovascular and ...

Home March 04, 2026
Home
News | ECG

Feb. 10, 2026 – AccurKardia, a provider of ECG-based diagnostics technology, recently announced results from a new study ...

Home February 24, 2026
Home
News | ECG

Feb. 18, 2026 — Researchers at the Mount Sinai Kravis Children’s Heart Center led a multicenter effort to develop and ...

Home February 20, 2026
Home
News | ECG

Dec. 10, 2025 — The U.S. Food and Drug Administration (FDA) has granted 510(k) clearance to HeartBeam, Inc. for its 12 ...

Home February 16, 2026
Home
Subscribe Now